Epirubicin

Epirubicin is a medicine known commercially as Nuovodox or Tecnomax.

This injectable drug is used to treat several types of cancer, reducing the tumor and the likelihood of metastasis.

Epirubicin Indications

Breast cancer; lung cancer; liver cancer; sarcoma (soft tissue); stomach cancer; bladder cancer.

Side Effects of Epirubicin

Nausea; vomiting; diarrhea; lack of appetite; mucositis; amenorrhea; lethargy; heat waves; fever; skin allergies; peeling of the skin; loss of hair; infection; irritation at the injection site; conjunctivitis.

Contraindications for Epirubicin

Pregnancy risk D; lactating women; stomatitis; widespread infections; history of arrhythmia; individuals with hypersensitivity to any component of the formula.

How to use Epirubicin

Injectable Use

Adults

• Standard dose: Apply 60 to 120 mg of Epirubicin intravenously, in a single dose or divided into 2 or 3 days in succession. Repeat the procedure every 3 or 4 weeks if the patient normalizes the drug-induced toxicity. Breast cancer: Apply 100 to 120 mg of Epirubicin intravenously, in a single dose or divided into 2 or 3 days in a row.